Suppr超能文献

角膜交联术治疗角膜移植术后圆锥角膜复发

Corneal cross-linking for treatment of keratoconus relapse in post-keratoplasty eyes.

机构信息

Goldschleger Eye Institute, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Hashomer, Israel.

Department of Ophthalmology, University Hospital Carl Gustav Carus, Technical University, Dresden, Germany.

出版信息

Int Ophthalmol. 2023 Nov;43(11):4027-4034. doi: 10.1007/s10792-023-02807-x. Epub 2023 Jul 12.

Abstract

PURPOSE

Keratoconus relapse after penetrating keratoplasty is a rare condition that may result in severe visual deterioration and corneal graft thinning. Therefore, treatment to stabilize the cornea should be considered. The purpose of this study was to evaluate the safety and efficacy of Corneal Cross-Linking (CXL) in eyes with relapse of keratoconus after penetrating keratoplasty for keratoconus.

MATERIALS AND METHODS

A retrospective review of eyes that developed keratoconus relapse following a penetrating keratoplasty and treated with CXL. The main outcome measures were change in maximal keratometry (Kmax), best-corrected distance visual acuity (BCVA), thinnest corneal thickness (TCT) and central corneal thickness (CCT), and complications.

RESULTS

We identified 10 consecutive eyes of 9 patients. Preoperative median BCVA before the CXL and 1 year after the CXL procedure remained stable (p = 0.68). The median (IQR) of Kmax improved from 63.2 (24.9) D before the CXL procedure to 62.2 (27.1) D at 1 year postoperatively (P = 0.028). Median TCT and CCT also remained with no significant change 1 year after CXL. No complications were noted following the procedure.

CONCLUSION

CXL in eyes with keratoconus relapse after keratoplasty is a safe and effective procedure enabling not only visual stabilization but also might bring keratometry improvement. Routine follow-up after keratoplasty should be performed for early detection of keratoconus relapse and CXL is timely advised when such a relapse is documented.

摘要

目的

穿透性角膜移植术后圆锥角膜复发是一种罕见的情况,可能导致严重的视力恶化和角膜移植物变薄。因此,应考虑治疗以稳定角膜。本研究的目的是评估角膜交联(CXL)在穿透性角膜移植术后圆锥角膜复发的眼中的安全性和有效性。

材料和方法

回顾性分析了穿透性角膜移植术后发生圆锥角膜复发并接受 CXL 治疗的眼睛。主要观察指标为最大角膜曲率(Kmax)、最佳矫正远视力(BCVA)、最薄角膜厚度(TCT)和中央角膜厚度(CCT)的变化以及并发症。

结果

我们确定了 9 例患者的 10 只连续眼。CXL 前和 CXL 后 1 年的术前中位 BCVA 保持稳定(p = 0.68)。Kmax 的中位数(IQR)从 CXL 前的 63.2(24.9)D 改善至术后 1 年的 62.2(27.1)D(P = 0.028)。CCT 和 TCT 的中位数在 CXL 后 1 年也没有明显变化。手术后没有观察到任何并发症。

结论

对于角膜移植术后圆锥角膜复发的患者,CXL 是一种安全有效的方法,不仅可以稳定视力,还可能改善角膜曲率。角膜移植术后应进行常规随访,以便早期发现圆锥角膜复发,一旦发现复发,应及时建议进行 CXL。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验